EDWARDS LIFESCIENCES LLC EDWARDS INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE
|
Back to Search Results |
|
Model Number 11500A |
Device Problems
Gradient Increase (1270); Insufficient Information (3190)
|
Patient Problems
Heart Failure/Congestive Heart Failure (4446); Insufficient Information (4580)
|
Event Date 08/10/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
H10: additional manufacturer narrative: the subject device is not available for evaluation, as it remains implanted in the patient.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
|
Event Description
|
It was reported that a patient with a 21mm 11500a aortic valve is being evaluated for a valve in valve procedure after an implant duration of two years, four months due to unknown reason.The procedure has not scheduled yet.
|
|
Manufacturer Narrative
|
The device history record (dhr) could not be reviewed, as the device serial number was not provided.Engineering evaluation summary: stenosis, which develops progressively over time, can be due to a number of issues.Additionally, there can be a number of potentials known and unknown patient-related contributing factors.Per technical summary 33069, rev a, structural valve deterioration (svd) is the most common reason for bioprosthesis explant and encompasses multiple failure modes, including calcification, noncalcific degeneration, dehiscence, cusp thickening or fibrosis, or a combination of these.Such failure modes, occurring singularly or concomitantly, may contribute to stenosis and/or regurgitation.Alternatively, non-structural valve dysfunction (nsvd) may also play a role in the development of valvular stenosis.Stenosis is most commonly related to patient factors and is not usually an indication of a device malfunction.The most likely cause is patient factors, including a history of cabg and cad.All pertinent information available to edwards lifesciences has been submitted.
|
|
Event Description
|
It was reported and learned through medical records that a patient with a 21mm 11500a aortic valve underwent a valve in valve procedure after an implant duration of two (2) years, four (4) months and 21 days due to severe stenosis.The patient presented with chronic diastolic heart failure.The tavr was completed with a 26mm 9755rsl transcatheter valve without complication and patient was stable in icu.
|
|
Manufacturer Narrative
|
The device history record (dhr) was not able to be reviewed as the device serial number was not provided.Edwards will continue to review and monitor all events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.Engineering evaluation summary: attempts have been made to obtain missing information; however, to date, no response has been received.Since there is no information regarding an allegation of a device malfunction, an engineering evaluation is not required.Based on the information available, a definitive root cause cannot be conclusively determined.All pertinent information available to edwards lifesciences has been submitted.
|
|
Search Alerts/Recalls
|
|
|